Live from the NIH registry
Studies recruiting near Dallas right now
Top 25 of 1,868 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Prostate Cancer, Prostate Adenocarcinoma
Phase 2
Interventional 90 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: University of Chicago
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Sarah Cannon Research Institute at Mary Crowley — Dallas, Texas (2.4 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Medical City Dallas Hospital — Dallas, Texas (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
UT Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: Pacific Edge Limited
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Locally Advanced Solid Tumor, Metastatic Solid Tumor
Phase 1
Interventional 30 participants sought
Texas Oncology — Dallas, Texas (2.4 mi)
· Sponsor: Acepodia Biotech, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Texas Oncology - DFW — Dallas, Texas (2.4 mi)
· Sponsor: SCRI Development Innovations, LLC
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
PIK3CA Mutation, HER2- Negative Breast Cancer
Phase 3
Interventional 540 participants sought
Texas Oncology DFW — Dallas, Texas (2.4 mi)
· Sponsor: Relay Therapeutics, Inc.
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Triple Negative Breast Cancer, HER2-negative Breast Cancer
Phase 1
Interventional 96 participants sought
Dren Investigational Site — Dallas, Texas (2.4 mi)
· Sponsor: Dren Bio
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease, GM1 Gangliosidosis or GM2 Gangliosidosis
Niemann-Pick Type C Disease, GM1 Gangliosidosis
Phase 3
Interventional 147 participants sought
Children's Medical Center Dallas — Dallas, Texas (2.4 mi)
· Sponsor: Azafaros B.V.
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Dallas — Dallas, Texas (2.4 mi)
· Sponsor: RAI Services Company
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
Physical Inactivity, Phosphate Overload
N/A
Interventional 124 participants sought
University of Texas Southwestern — Dallas, Texas (2.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
International obServational sTudy on AiRway manaGement in operAting Room and Non-operaTing Room anaEsthesia
Airway Complication of Anesthesia
N/A
Observational 10,500 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: University of Turin, Italy
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 168 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: OncoNano Medicine, Inc.
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
US Renal Care — Waxahachie, Texas (28.5 mi)
· Sponsor: R1 Therapeutics
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
UT Southwestern Medical Center ( Site 0190) — Dallas, Texas (2.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
Locally Advanced or Metastatic Solid Tumors, Colorectal Cancer
Phase 1
Interventional 572 participants sought
NEXT Dallas — Irving, Texas (10.7 mi)
· Sponsor: ArriVent BioPharma, Inc.
tAN for First Responders
Mental Fatigue, Mental Stress
N/A
Interventional 30 participants sought
Spark Biomedical - DECENTRALIZED STUDY — Dallas, Texas (2.4 mi)
· Sponsor: Spark Biomedical, Inc.
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Tekton Research — McKinney, Texas (29.3 mi)
· Sponsor: Medtronic MiniMed, Inc.
A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
Hidradenitis Suppurativa
Phase 2
Interventional 90 participants sought
Texas Dermatology Research Center — Dallas, Texas (2.4 mi)
· Sponsor: Takeda
Adult and Juvenile Myositis
Dermatomyositis, Polymyositis
N/A
Observational 1,200 participants sought
Texas Scottish Rite Hospital — Dallas, Texas (2.4 mi)
· Sponsor: National Institute of Environmental Health Sciences (NIEHS)
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated With Radiation
Cancer
N/A
Observational 10,000 participants sought
UT Southwestern Medical Centre — Dallas, Texas (2.4 mi)
· Sponsor: University of Texas Southwestern Medical Center
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma
Phase 2
Interventional 81 participants sought
Parkland Memorial Hospital — Dallas, Texas (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients
LCA5
Phase 1, Phase 2
Interventional 22 participants sought
Retina Foundation of the Southwest — Dallas, Texas (2.4 mi)
· Sponsor: Opus Genetics, Inc
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
Large Cell Lymphoma, Diffuse, Relapsed Cancer
Phase 2
Interventional 35 participants sought
University of Texas Southwestern Medical Center — Dallas, Texas (2.4 mi)
· Sponsor: Dipenkumar Modi
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Dallas, Texas (2.4 mi)
· Sponsor: AstraZeneca